Quick Search

 

 


 

 

Home > Result Summaries: Compounds > argatroban > Result Summary for ARG-402

Result Summary for ARG-402

Result Summary
Protocol ID: ARG-402
Clinical Study ID: ARG-402
Official Title: Pharmacokinetics and Pharmacodynamics of Argatroban Injection in End-Stage Renal Disease (ESRD) Patients Undergoing Hemodialysis
Phase: Phase 2
Study Indications or Diseases:
  • Anticoagulation
Generic Name: argatroban
Trade/Product Name: argatroban;argatroban
Approved Drug Label: http://www.gsk.com/products.html
Results Summary: Click here to download result summary. Click here to download result summary.
Citations:
  • Murray PT, Reddy B, Grossman EJ, et al. A prospective comparison of three argatroban treatment regimens during hemodialysis in end-stage renal disease. Kidney International 2004:66:2446-2453.

The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.